206 related articles for article (PubMed ID: 17015787)
1. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
Gudmundsdóttir IJ; Megson IL; Kell JS; Ludlam CA; Fox KA; Webb DJ; Newby DE
Circulation; 2006 Oct; 114(15):1625-32. PubMed ID: 17015787
[TBL] [Abstract][Full Text] [Related]
2. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
[TBL] [Abstract][Full Text] [Related]
3. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro.
Tognetto M; D'Andrea MR; Trevisani M; Guerrini R; Salvadori S; Spisani L; Daniele C; Andrade-Gordon P; Geppetti P; Harrison S
Br J Pharmacol; 2003 May; 139(1):21-7. PubMed ID: 12746219
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
Murphey LJ; Malave HA; Petro J; Biaggioni I; Byrne DW; Vaughan DE; Luther JM; Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2006 Sep; 318(3):1287-92. PubMed ID: 16772538
[TBL] [Abstract][Full Text] [Related]
6. Vascular effects of apelin in vivo in man.
Japp AG; Cruden NL; Amer DA; Li VK; Goudie EB; Johnston NR; Sharma S; Neilson I; Webb DJ; Megson IL; Flapan AD; Newby DE
J Am Coll Cardiol; 2008 Sep; 52(11):908-13. PubMed ID: 18772060
[TBL] [Abstract][Full Text] [Related]
7. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
[TBL] [Abstract][Full Text] [Related]
8. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
9. Endothelial protease-activated receptor-2 induces tissue factor expression and von Willebrand factor release.
Langer F; Morys-Wortmann C; Küsters B; Storck J
Br J Haematol; 1999 May; 105(2):542-50. PubMed ID: 10233435
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular actions of thrombin receptor activation in vivo.
Damiano BP; Cheung WM; Mitchell JA; Falotico R
J Pharmacol Exp Ther; 1996 Dec; 279(3):1365-78. PubMed ID: 8968361
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
12. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
13. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
14. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells.
Hamilton JR; Chow JM; Cocks TM
Br J Pharmacol; 1999 Jun; 127(3):617-22. PubMed ID: 10401551
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.
Derian CK; Damiano BP; Addo MF; Darrow AL; D'Andrea MR; Nedelman M; Zhang HC; Maryanoff BE; Andrade-Gordon P
J Pharmacol Exp Ther; 2003 Feb; 304(2):855-61. PubMed ID: 12538843
[TBL] [Abstract][Full Text] [Related]
18. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6.
Newby DE; Stewart A; Witherow FN; Grieve S; Dawson P; Fox KA; Webb DJ; Ludlam CA
Thromb Haemost; 2000 Aug; 84(2):195-203. PubMed ID: 10959689
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of thrombin- and SFLLRN-induced aggregation of human platelets in flow through tubes.
Goldsmith HL; McIntosh FA; Frojmovic MM
Biorheology; 1998; 35(1):53-68. PubMed ID: 10211129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
